Compounding Chemotherapy Market to Reach $6.3 Billion by 2027 in the short run and $9.8 Billion by 2034 Globally, at 6.4% CAGR: Allied Market Research ...

Facing increased competition in the weight loss market and intense pressure from President Donald Trump, Novo Nordisk announced Monday that it is lowering prices for its blockbuster obesity and ...

Digital health company Waltz Health said on Friday it has launched a program to offer popular weight-loss drugs from Novo ...

For many men, the gradual thinning of hair is about more than just their appearance. Finasteride, a drug widely prescribed for the treatment of male pattern baldness has been used effectively for many ...

“The best ideas in drug discovery were often blocked not by biology, but by synthesis,” Boiko told TechCrunch. Synthesis is ...

That said, GLP-1 medications for weight loss are not for everyone, and they can cause unpleasant, even serious, side effects, ...

From idea, to lab, to clinic, to approval—it's a long and expensive process to bring a drug to market. It also rarely ...

Studies in animals have found some of these dyes can cause cancer in rats (though the FDA says the same mechanism is not ...

During the inquiry, Regen Doctors informed the National Advertising Division (NAD) that it had permanently discontinued the challenged claims. Therefore, NAD did not review the claims on their merits ...

Novo Nordisk A/S is undercutting archrival Eli Lilly & Co. on obesity drugs for cash-pay patients, showing its willingness to ...

Forbes Health has ranked the best providers for pricing, patient care, effectiveness and ease of use. This way you can cut through the scams and noise to make an informed decision when choosing an ...

A new chemical compound has shown promise for treating Alzheimer's disease. Its effects in a rat model of the disease were ...